Arkolith/Insider Trading/IMMX/Form 4

Rachman Ilya M

CEO and Chairman, DirectorImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed Nov 15, 2022
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2022Buy(P)150$0.99$149908K
Nov 14, 2022Buy(P)4K$1.02$4K907K
Nov 14, 2022Buy(P)1K$0.95$950908K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-032557) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML